Benjamin R. Plaisance, M.D.

NPI 1992905897ActiveIndividual· Internal Medicine, Cardiovascular Disease· Birmingham, AL

Internal Medicine, Cardiovascular Disease (M.D.) in Birmingham, Alabama, trained at University of Alabama School of Medicine (class of 2007). Their prescriptions cost Medicare Part D more than their services did: $1,942,533 for 9,741 claims, against $222,853 paid for services in 2024. Novo Nordisk Inc was the largest of 3 companies reporting payments in 2025, $48.59 in all, mostly food and beverage.

Overview

NPI	1992905897
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	Yes
NPI issued	Jul 19, 2007
Last updated in NPPES	Dec 4, 2020
Certified by provider	Dec 4, 2020

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Cardiovascular Disease Primary	207RC0000X	32395	AL
Internal Medicine	207R00000X	43631	KY
Student in an Organized Health Care Education/Training Program	390200000X	10782697	KY

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Cardiovascular Disease (Cardiology) (AL)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	940
Services billed	3,578 across 69 procedure codes
Paid by Medicare	$222,853

Part D prescriptions in 2024

Prescriptions (claims)	9,741 · 24,537 30-day fills
Patients	1,341
Total drug cost	$1,942,533
Generic share	82% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Alabama School of Medicine
Graduation year	2007
Medicare specialty	Cardiovascular Disease (Cardiology)
Secondary specialties	Interventional Cardiology